These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36982202)

  • 1. Cytogenetic Damage Induced by Radioiodine Therapy: A Follow-Up Case Study.
    Khvostunov IK; Nasonova E; Krylov V; Rodichev A; Kochetova T; Shepel N; Korovchuk O; Kutsalo P; Shegai P; Kaprin A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent in vivo cytogenetic effects of radioiodine therapy: a 21-year follow-up study using multicolor FISH.
    Livingston GK; Escalona M; Foster A; Balajee AS
    J Radiat Res; 2018 Jan; 59(1):10-17. PubMed ID: 29036595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer.
    Khvostunov IK; Saenko VA; Krylov V; Rodichev A; Yamashita S
    Radiat Environ Biophys; 2017 Aug; 56(3):213-226. PubMed ID: 28526978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic effects of radioiodine therapy: a 20-year follow-up study.
    Livingston GK; Khvostunov IK; Gregoire E; Barquinero JF; Shi L; Tashiro S
    Radiat Environ Biophys; 2016 May; 55(2):203-13. PubMed ID: 27015828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equal induction and persistence of chromosome aberrations involving chromosomes 1, 4 and 10 in thyroid cancer patients treated with radioactive iodine.
    Puerto S; Marcos R; Ramírez MJ; Galofré P; Creus A; Surrallés J
    Mutat Res; 2000 Aug; 469(1):147-58. PubMed ID: 10946251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenetic study of thyroid patients treated with external irradiation or radioiodine].
    Katz N; Esik O; Füzy M; Gundy S
    Orv Hetil; 1998 Jun; 139(25):1521-6. PubMed ID: 9676113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer.
    Abe K; Ishizaki U; Ono T; Horiuchi K; Kanaya K; Sakai S; Okamoto T
    Ann Nucl Med; 2020 Feb; 34(2):144-151. PubMed ID: 31834567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective Evaluation of Cytogenetic Effects Induced by Internal Radioiodine Exposure: A 27-Year Follow-Up Study.
    Livingston GK; Ryan TL; Escalona MB; Foster AE; Balajee AS
    Cytogenet Genome Res; 2023; 163(3-4):154-162. PubMed ID: 37573786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Simple, Complex, and Clonal Chromosome Translocations Induced by Internal Radioiodine Exposure: A Cytogenetic Follow-Up Case Study after 25 Years.
    Livingston GK; Ryan TL; Smith TL; Escalona MB; Foster AE; Balajee AS
    Cytogenet Genome Res; 2019; 159(4):169-181. PubMed ID: 31846971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of chromosome painting. II. A detailed analysis of aberrations following high doses of ionizing radiation in vitro.
    Tucker JD; Lee DA; Moore DH
    Int J Radiat Biol; 1995 Jan; 67(1):19-28. PubMed ID: 7531743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Inter-chromosomal Stable Aberrations by Multiple Fluorescence In Situ Hybridization (mFISH) and Spectral Karyotyping (SKY) in Irradiated Mice.
    Pathak R; Koturbash I; Hauer-Jensen M
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131.
    M'Kacher R; Schlumberger M; Légal JD; Violot D; Béron-Gaillard N; Gaussen A; Parmentier C
    J Nucl Med; 1998 May; 39(5):825-9. PubMed ID: 9591584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is 24-color FISH detection of in-vitro radiation-induced chromosomal aberrations suited to determine individual intrinsic radiosensitivity?
    Kuechler A; Neubauer S; Grabenbauer GG; Claussen U; Liehr T; Sauer R; Wendt TG
    Strahlenther Onkol; 2002 Apr; 178(4):209-15. PubMed ID: 12040758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma.
    M'Kacher R; Légal JD; Schlumberger M; Aubert B; Beron-Gaillard N; Gaussen A; Parmentier C
    J Nucl Med; 1997 Mar; 38(3):377-80. PubMed ID: 9074522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study on potential cytogenetic fingerprints for radiation LET in human lymphocytes.
    Deng W; Morrison DP; Gale KL; Lucas JN
    Int J Radiat Biol; 2000 Dec; 76(12):1589-98. PubMed ID: 11133040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic study of radiation burden in thyroid disease patients treated with external irradiation or radioiodine.
    Gundy S; Katz N; Füzy M; Esik O
    Mutat Res; 1996 Jun; 360(2):107-13. PubMed ID: 8649463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokinesis-block micronucleus test in patients undergoing radioiodine therapy for differentiated thyroid carcinoma.
    Popova L; Hadjidekova V; Hadjieva T; Agova S; Vasilev I
    Hell J Nucl Med; 2005; 8(1):54-7. PubMed ID: 15886755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma.
    M'Kacher R; Legal JD; Schlumberger M; Voisin P; Aubert B; Gaillard N; Parmentier C
    J Nucl Med; 1996 Nov; 37(11):1860-4. PubMed ID: 8917193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinoma.
    Thies ED; Tanase K; Maeder U; Luster M; Buck AK; Hänscheid H; Reiners C; Verburg FA
    Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2281-90. PubMed ID: 25030619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy.
    Eberlein U; Scherthan H; Bluemel C; Peper M; Lapa C; Buck AK; Port M; Lassmann M
    J Nucl Med; 2016 Feb; 57(2):173-9. PubMed ID: 26564321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.